Vandana Singh
·
December 5, 2024
Benzinga
AstraZeneca's Imfinzi gains FDA approval for LS-SCLC after ADRIATIC trial shows survival benefits. Separate trials explore additional cancer therapies.
read more
January 10, 2025
January 2, 2025
January 1, 2025
Financial Times
January 6, 2025
January 7, 2025
Bloomberg